Congo Approves use of Experimental Ebola Vaccine, WHO Says

KINSHASA, Congo (AP) — Congo has agreed to allow the World Health Organization to use an experimental Ebola vaccine to combat an outbreak announced last week, the WHO director-general said Monday. The aim is for health officials to start using the vaccine, once it's shipped, by the end of the week, or next week if there are difficulties, said WHO Director-General Tedros Adhanom Ghebreyesus. "We have agreement, registration, plus import permit — everything formally agreed already. And as you know that vaccine is safe and efficacious and has been already tested. So I think we can all be prepared," he said. "All is ready now, to use it." The outbreak was announced last week in Bikoro, in Congo's northwest. Health officials traveled there after Congo's Equateur provincial health ministry on May 3 alerted them to 17 deaths from a hemorrhagic fever. As of May 13, Congo has 39 suspected, probable and confirmed cases of Ebola since April, including 19 deaths, WHO reported. Two cases of Ebola have been confirmed. Congo's Ministry of Health has requested that WHO send 4,000 doses of the vaccine, said ministry spokeswoman Jessyca Ilunga, who said they should arrive by the end of the week. "The vaccination campaign starts next week, everything depends on the logistics because the vaccine must be kept at minus 60 degrees Celsius, and we need to assure that the cold chain is assured from Geneva to Bikoro," she said. The Ebola vaccination campaign will firs...
Source: JEMS: Journal of Emergency Medical Services News - Category: Emergency Medicine Authors: Tags: Patient Care News Source Type: news